$231.45
6.23[2.77%]
Last update: 1:44PM Get Real Time Here
Inspire Medical Systems
(NYSE:INSP)Inspire Medical Systems Stock (NYSE:INSP), Analyst Ratings, Price Targets, Predictions
Inspire Medical Systems Inc has a consensus price target of $264.1, established from looking at the 63 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Mizuho, and Truist Securities on April 19, 2024, March 27, 2024, and March 20, 2024. With an average price target of $271.67 between RBC Capital, Mizuho, and Truist Securities, there's an implied 20.62% upside for Inspire Medical Systems Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Mizuho
Truist Securities
Morgan Stanley
Keybanc
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Inspire Medical Systems
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/19/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 26.54% | RBC Capital | Shagun Singh | → $285 | Initiates | → Outperform | Get Alert |
| 03/27/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 11% | Mizuho | Anthony Petrone | $250 → $250 | Maintains | Buy | Get Alert |
| 03/20/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 24.32% | Truist Securities | Richard Newitter | → $280 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 11% | Morgan Stanley | Kallum Titchmarsh | → $250 | Initiates | → Overweight | Get Alert |
| 02/07/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 24.32% | Truist Securities | Richard Newitter | $265 → $280 | Maintains | Buy | Get Alert |
| 02/07/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 11% | Mizuho | Anthony Petrone | $225 → $250 | Maintains | Buy | Get Alert |
| 02/06/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 23.43% | Keybanc | Brett Fishbin | → $278 | Initiates | → Overweight | Get Alert |
| 01/19/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 8.78% | Jefferies | — | → $245 | Initiates | → Buy | Get Alert |
| 01/02/2024 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -6.76% | Stifel | Jonathan Block | → $210 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 15.44% | Truist Securities | Richard Newitter | $240 → $260 | Maintains | Buy | Get Alert |
| 12/13/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -16.97% | Wells Fargo | Larry Biegelsen | → $187 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/08/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -6.76% | Stifel | Jonathan Block | $250 → $210 | Maintains | Buy | Get Alert |
| 11/08/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -4.54% | Mizuho | Anthony Petrone | $300 → $215 | Maintains | Buy | Get Alert |
| 11/08/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 6.56% | Truist Securities | Richard Newitter | $260 → $240 | Maintains | Buy | Get Alert |
| 11/08/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 8.78% | Wells Fargo | Larry Biegelsen | $330 → $245 | Maintains | Overweight | Get Alert |
| 11/07/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 11% | Stifel | Jonathan Block | $350 → $250 | Maintains | Buy | Get Alert |
| 10/17/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -19.63% | JP Morgan | Robbie Marcus | $340 → $181 | Maintains | Overweight | Get Alert |
| 10/16/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | -29.4% | Leerink Partners | Mike Kratky | → $159 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | INSP | Buy Now | Inspire Medical Systems | $225.22 | 50.96% | Truist Securities | Richard Newitter | → $340 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Inspire Medical Systems (INSP)?
The latest price target for Inspire Medical Systems (NYSE: INSP) was reported by RBC Capital on April 19, 2024. The analyst firm set a price target for $285.00 expecting INSP to rise to within 12 months (a possible 23.14% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inspire Medical Systems (INSP)?
The latest analyst rating for Inspire Medical Systems (NYSE: INSP) was provided by RBC Capital, and Inspire Medical Systems initiated their outperform rating.
When was the last upgrade for Inspire Medical Systems (INSP)?
The last upgrade for Inspire Medical Systems Inc happened on December 13, 2022 when Goldman Sachs raised their price target to N/A. Goldman Sachs previously had a neutral for Inspire Medical Systems Inc.
When was the last downgrade for Inspire Medical Systems (INSP)?
The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.
When is the next analyst rating going to be posted or updated for Inspire Medical Systems (INSP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on April 19, 2024 so you should expect the next rating to be made available sometime around April 19, 2025.
Is the Analyst Rating Inspire Medical Systems (INSP) correct?
While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a initiated with a price target of $0.00 to $285.00. The current price Inspire Medical Systems (INSP) is trading at is $231.45, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.